Isoniazid Induction of Antinuclear Antibodies

Publisher Website
Google Scholar
Abstract
Patients (102) admitted to the Chest Service with tuberculosis were studied. Four patients (4%) had antinuclear antibodies before therapy and 22 patients (21.6%) developed antinuclear antibodies after treatment. None developed lupus erythematosus cells or signs or symptoms of systemic lupus erythematosus. Age and race were not related to the induction of antinuclear antibodies. The percent of positive sera was similar during and after 3 mo. of treatment, with higher titers after 3 mo. of therapy. Although patients were treated with various antituberculosis drugs, isoniazid alone or in combination with other drugs induced antinuclear antibodies.